Healthcare > Medical Devices & Equipment
•1105 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1105)
| Company | Market Cap | Price |
|---|---|---|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$553.45M |
$16.57
-2.27%
|
|
VPG
Vishay Precision Group, Inc.
Medical infusion pump design win indicates participation in the Medical Devices & Biometrics market.
|
$553.34M |
$41.53
+2.85%
|
|
DNA
Ginkgo Bioworks Holdings, Inc.
Laboratory Testing & Advisory Services aligns with CRO-type fee-for-service capabilities.
|
$547.01M |
$9.37
+3.37%
|
|
ORGO
Organogenesis Holdings Inc.
Core wound care device category covering Apligraf and Dermagraft, along with barrier products like PuraPly and FortiShield.
|
$534.07M |
$4.17
-1.07%
|
|
ZIMV
ZimVie Inc.
Prosthetics & Implants—core product line includes dental implants and related prosthetic solutions.
|
$530.23M |
$18.99
|
|
NUS
Nu Skin Enterprises, Inc.
The Prysm iO and related wellness devices involve medical/biometric device technology.
|
$511.31M |
$10.36
+0.34%
|
|
DBVT
DBV Technologies S.A.
Viaskin patch is a medical device delivering therapy; categorize under Medical Devices & Biometrics.
|
$465.98M |
$16.99
-0.06%
|
|
CYH
Community Health Systems, Inc.
CYH directly provides hospital inpatient and outpatient care services through a network of hospitals and related facilities.
|
$465.20M |
$3.31
-1.34%
|
|
KOPN
Kopin Corporation
CR3 medical headset and defense medical imaging/biometric sensing align with Medical Devices & Biometrics.
|
$462.37M |
$2.85
-3.23%
|
|
KIDS
OrthoPediatrics Corp.
Directly manufactures pediatric orthopedic implants and devices (plates, screws, growing rods, braces), the core product category for the company.
|
$459.10M |
$18.27
-2.43%
|
|
MLAB
Mesa Laboratories, Inc.
Clinical Genomics hardware (MassARRAY) is diagnostic equipment used in regulated lab environments, fitting Diagnostic Equipment.
|
$446.66M |
$81.02
-3.87%
|
|
BWAY
BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
|
$436.66M |
$22.84
-1.08%
|
|
MG
Mistras Group, Inc.
MG provides Laboratory Testing & Advisory Services as part of its inspection and testing offerings.
|
$433.65M |
$13.62
+1.23%
|
|
CLPT
ClearPoint Neuro, Inc.
ClearPoint's core offerings include neurosurgical navigation hardware and related surgical equipment (e.g., ClearPoint system, Prism Laser Therapy, Velocity Alpha drill).
|
$424.14M |
$15.31
+0.03%
|
|
ANGO
AngioDynamics, Inc.
Core product category: vascular intervention devices, including Auryon, AlphaVac, and AngioVac.
|
$406.23M |
$9.96
-0.90%
|
|
CERS
Cerus Corporation
Cerus' INTERCEPT Blood System is a medical device platform; primary product is a device used in transfusion safety.
|
$394.90M |
$2.04
-2.15%
|
|
SGHT
Sight Sciences, Inc.
Directly manufactures ophthalmic surgical devices (OMNI Surgical System, TearCare-related tools) used in eye care, i.e., ophthalmology devices.
|
$376.00M |
$7.12
-5.44%
|
|
QTRX
Quanterix Corporation
Quanterix directly manufactures and sells ultra-sensitive diagnostic instruments (Simoa platforms) used for biomarker detection in blood and other samples.
|
$374.52M |
$8.25
+26.73%
|
|
TLSI
TriSalus Life Sciences, Inc.
TriNav and related systems are vascular intervention devices used for embolization and targeted drug delivery.
|
$370.02M |
$7.32
+0.48%
|
|
DCTH
Delcath Systems, Inc.
The company sells medical device technology (hepatic delivery system) and related procedures.
|
$361.71M |
$10.37
+1.57%
|
|
RXST
RxSight, Inc.
RxSight's core offering is the Light Adjustable Lens system and related ophthalmic devices used in premium cataract surgery, which fits Ophthalmology Devices.
|
$361.70M |
$8.73
-8.78%
|
|
AUNA
Auna S.A.
AUNA operates hospitals and provides inpatient and outpatient care, i.e., hospital services.
|
$360.98M |
$4.88
-2.10%
|
|
SOPH
SOPHiA GENETICS S.A.
Liquid Biopsy: MSK-ACCESS application and liquid biopsy analytics integrated into the platform.
|
$357.50M |
$5.29
+6.55%
|
|
MTLS
Materialise N.V.
Materialise's Mimics platform centers on medical imaging analysis and planning workflows.
|
$340.82M |
$5.75
-2.21%
|
|
AHG
Akso Health Group
Sale of medical devices and biometrics hardware.
|
$330.74M |
$1.56
+17.29%
|
|
NVEC
NVE Corporation
Medical devices & biometrics applications, including implantable sensors and collaboration with Abbott.
|
$308.08M |
$63.89
+0.27%
|
|
SCPH
scPharmaceuticals Inc.
Auto-Injector Devices reflect the SCP-111 autoinjector program for at-home administration.
|
$299.33M |
$5.67
|
|
DDD
3D Systems Corporation
Offers dental equipment and dental 3D printing solutions (NextDent).
|
$298.83M |
$2.31
-9.96%
|
|
SENS
Senseonics Holdings, Inc.
Senseonics develops and markets implantable medical devices and biometric sensing technologies (Eversense CGM), fitting the Medical Devices & Biometrics investable theme.
|
$294.10M |
$7.12
-0.07%
|
|
SMLR
Semler Scientific, Inc.
QuantaFlo is a diagnostic device used to measure arterial blood flow for PAD, directly constituting Diagnostic Equipment.
|
$286.77M |
$19.51
-5.61%
|
|
LFCR
Lifecore Biomedical, Inc.
New 5-head aseptic isolator filler expands capacity for filling into prefilled syringes.
|
$279.91M |
$7.57
-2.57%
|
|
OWLT
Owlet, Inc.
Owlet sells FDA-cleared Medical Devices & Biometrics (Dream Sock and BabySat) with wearable biosensing capabilities.
|
$269.81M |
$15.27
-0.49%
|
|
SPOK
Spok Holdings, Inc.
GenA alphanumeric pager represents a medical device hardware line under Medical Devices & Biometrics.
|
$267.48M |
$12.99
-1.44%
|
|
SNWV
SANUWAVE Health, Inc.
SANUWAVE directly manufactures and markets medical devices (UltraMIST and related wound-care technology) and biometrics for patient care.
|
$265.44M |
$31.33
+2.39%
|
|
SY
So-Young International Inc.
Wuhan Miracle Laser integration indicates the company uses/markets medical devices and biometrics in aesthetics.
|
$262.21M |
$2.63
+0.96%
|
|
KRMD
KORU Medical Systems, Inc.
KRMD's core business is medical devices focused on patient-centric subcutaneous infusion systems (Freedom) and related components.
|
$261.23M |
$5.66
-2.67%
|
|
NAUT
Nautilus Biotechnology, Inc.
The hardware/assay suite functions as diagnostic-type equipment for proteomics analyses.
|
$260.19M |
$2.06
-6.98%
|
|
HBB
Hamilton Beach Brands Holding Company
Home health monitoring devices tied to HealthBeacon’s at-home patient monitoring platform and subscription model.
|
$259.15M |
$18.68
+10.34%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
AVIM therapy is an implantable cardiac stimulation-based treatment for hypertension, aligning with Cardiology Devices.
|
$258.98M |
$4.82
-0.41%
|
|
PROF
Profound Medical Corp.
Profound's flagship TULSA-PRO is a surgical device used for MR-guided prostate tissue ablation.
|
$253.65M |
$8.40
-0.94%
|
|
BNR
Burning Rock Biotech Limited
Burning Rock's brPROPHET MRD and MCED products are ctDNA-based diagnostics delivered as a liquid biopsy test.
|
$250.90M |
$22.85
-2.35%
|
Showing page 6 of 12 (1105 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
